CASC2 and glioma: Except for this unique role in inflammation response, CASC2 also functions as a tumor suppressor and it is downregulated in multiple cancer types including lung cancer 24, gastric cancer 25, colorectal cancer 26, bladder cancer 27, melanoma 28, and glioma 29.